Company: PHR
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001412408-25-000010
Chunk: 39

Company: Phreesia, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 39
---
 life(in years)Aggregate intrinsicvalueOutstanding — January 31, 20221,705,150 $6.01 Granted during the year— $— Exercised(311,743)$4.92 Forfeited and expired(8,214)$4.68 Outstanding and expected to vest — January 31, 20231,385,193 $6.26 5.06$43,341 Outstanding — January 31, 20231,385,193 $6.26 Granted during the year— $— Exercised(249,247)$3.42 Forfeited and expired(12,508)$5.87 Outstanding and expected to vest — January 31, 20241,123,438 $6.89 4.54$20,884 Outstanding — January 31, 20241,123,438 $6.89 Granted during the year— $— Exercised(220,523)$4.64 Forfeited and expired(3,534)$20.67 Outstanding and expected to vest — January 31, 2025899,381 $7.39 3.66$18,952 Exercisable — January 31, 2025899,381 $7.39 3.66$18,952 Amount vested during year ended January 31, 2025— $— 

100

The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company’s estimated stock price at the time of exercise and the exercise price, multiplied by the number of related in-the-money options) that would have been received by the option holders had they exercised their options at the end of the period. This amount changes based on the market value of the Company’s common stock. The total intrinsic value of options exercised for the years ended January 31, 2025, 2024 and 2023 (based on the difference between the Company’s estimated stock price on the exercise date and the respective exercise price, multiplied by the number of options exercised), was $4,210, $6,059 and $6,970, respectively.As of January 31, 2025, all compensation cost related to stock options issued to employees has been recorded and there is no unrecognized compensation cost remaining related to stock options issued to employees.(e) TSR performance